1. A review of the use of next generation sequencing methodologies to identify biomarkers of resistance to CDK4/6 inhibitors in ER+/HER2- breast cancer. (January 2021) Authors: Servetto, Alberto; Napolitano, Fabiana; De Angelis, Carmine; De Placido, Pietro; Giuliano, Mario; Arpino, Grazia; De Placido, Sabino; Bianco, Roberto; Formisano, Luigi Journal: Critical reviews in oncology/hematology Issue: Volume 157(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FGFR1 Antibody Validation and Characterization of FGFR1 Protein Expression in ER+ Breast Cancer. Issue 9 (12th October 2022) Authors: Gonzalez-Ericsson, Paula I.; Servetto, Alberto; Formisano, Luigi; Sánchez, Violeta; Mayer, Ingrid A.; Arteaga, Carlos L.; Sanders, Melinda E. Journal: Applied immunohistochemistry & molecular morphology Issue: Volume 30:Issue 9(2022) Page Start: 600 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FOLFIRINOX after first-line gemcitabine-based chemotherapy in advanced pancreatic cancer: a retrospective comparison with FOLFOX and FOLFIRI schedules. (September 2020) Authors: Foschini, Francesca; Napolitano, Fabiana; Servetto, Alberto; Marciano, Roberta; Mozzillo, Eleonora; Carratù, Anna Chiara; Santaniello, Antonio; De Placido, Pietro; Cascetta, Priscilla; Butturini, Giovanni; Frigerio, Isabella; Regi, Paolo; Silvestris, Nicola; Delcuratolo, Sabina; Vasile, Enrico; V... Journal: Therapeutic advances in medical oncology Issue: Volume 12(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Health-related quality of life is underestimated and underreported in phase III clinical trials in NSCLC. (December 2022) Authors: Salomone, Fabio; Di Costanzo, Fabrizio; Pecoraro, Giovanna; Viscardi, Giuseppe; Viggiano, Angela; Napolitano, Fabiana; Santaniello, Antonio; Formisano, Luigi; Bianco, Roberto; Servetto, Alberto Journal: Lung cancer Issue: Volume 174(2022) Page Start: 36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Inadequate health-related quality of life assessment and reporting in phase III clinical trials of immune checkpoint inhibitors in solid cancers: A systematic review. (April 2022) Authors: Servetto, Alberto; Salomone, Fabio; Di Costanzo, Fabrizio; Iuliano, Rossella; Marandino, Laura; Napolitano, Fabiana; Santaniello, Antonio; De Placido, Pietro; De Placido, Sabino; Di Maio, Massimo; Formisano, Luigi; Bianco, Roberto Journal: Critical reviews in oncology/hematology Issue: Volume 172(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Mechanisms of resistance to mTOR inhibitors. (March 2020) Authors: Formisano, Luigi; Napolitano, Fabiana; Rosa, Roberta; D'Amato, Valentina; Servetto, Alberto; Marciano, Roberta; De Placido, Pietro; Bianco, Cataldo; Bianco, Roberto Journal: Critical reviews in oncology/hematology Issue: Volume 147(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Role of FGFR3 in bladder cancer: Treatment landscape and future challenges. (April 2023) Authors: Ascione, Claudia Maria; Napolitano, Fabiana; Esposito, Daniela; Servetto, Alberto; Belli, Stefania; Santaniello, Antonio; Scagliarini, Sarah; Crocetto, Felice; Bianco, Roberto; Formisano, Luigi Journal: Cancer treatment reviews Issue: Volume 115(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗